110 related articles for article (PubMed ID: 9135972)
1. CD2 related immunoregulation in oral cancer.
Balaram P; Meenattoor G; Nalinakumari KR; Hareendran NK; Padmanabhan TK; Nair MK
Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):43-6. PubMed ID: 9135972
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
[TBL] [Abstract][Full Text] [Related]
3. Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor.
Kerishnan JP; Gopinath SC; Kai SB; Tang TH; Ng HL; Rahman ZA; Hashim U; Chen Y
Int J Med Sci; 2016; 13(6):424-31. PubMed ID: 27279791
[TBL] [Abstract][Full Text] [Related]
4. Sheep erythrocyte rosetting induces multiple alterations in T lymphocyte function: inhibition of T cell receptor activity and stimulation of T11/CD2.
Breitmeyer JB; Faustman DL
Cell Immunol; 1989 Oct; 123(1):118-33. PubMed ID: 2570643
[TBL] [Abstract][Full Text] [Related]
5. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in sera of patients with oral cancer.
Chatterjee R; Guha S
J Clin Lab Immunol; 1984 Nov; 15(3):145-7. PubMed ID: 6530696
[TBL] [Abstract][Full Text] [Related]
7. Specific components found in circulating immune complexes (CIC) in paracoccidioidomycosis.
Unterkircher CS; Yazaki SC; Shimizu MT; Jorge AO; Camargo ZP
J Med Vet Mycol; 1996; 34(4):273-7. PubMed ID: 8873887
[TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulins G, A, M and circulatory immune complexes in patients with laryngeal carcinoma].
Dimitrijević MV; Djordević V; Arsović N; Jeremić PD; Slijepcević NA; Konjević G
Acta Chir Iugosl; 2009; 56(3):45-9. PubMed ID: 20218101
[TBL] [Abstract][Full Text] [Related]
9. Serum circulating immune complexes as prognostic indicators in premalignant and malignant lesions of oral cavity during and following radiotherapy.
Rai S; Mody RN
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S116-22. PubMed ID: 22322729
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the oral cavity evaluated by specific red cell adherence test.
Liu PI; McGregor DH; Liu JG; Dunlap CL; Jinks WL; Lin F; Przybylski C; Miller LA
Oral Surg Oral Med Oral Pathol; 1974 Jul; 38(1):56-64. PubMed ID: 4525948
[No Abstract] [Full Text] [Related]
11. The influence of CD44 splice variants to the outcome of patients with oral squamous cell carcinoma.
Stoll C; Baretton G; Soost F; Löhrs U
Adv Exp Med Biol; 1998; 451():51-5. PubMed ID: 10026849
[No Abstract] [Full Text] [Related]
12. Loss of epithelial blood group substance A in oral carcinomas.
Dabelsteen E; Pindborg JJ
Acta Pathol Microbiol Scand A; 1973 Jul; 81(4):435-44. PubMed ID: 4130926
[No Abstract] [Full Text] [Related]
13. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients--a follow up study.
Parveen S; Taneja N; Bathi RJ; Deka AC
Indian J Dent Res; 2010; 21(1):10-5. PubMed ID: 20427899
[TBL] [Abstract][Full Text] [Related]
15. Hypocomplementemia and human immunodeficiency virus infection. Clinical correlates and relationships to circulating immune complex and immunoglobulin G levels.
Lin RY; Wildfeuer O; Franklin MM; Candido K
Int Arch Allergy Appl Immunol; 1988; 87(1):40-6. PubMed ID: 3170007
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulation of T-lymphocytes by autologous serum in oral-cancer.
Meenattoor G; Balaram P; Hareendran N; Abraham T; Nalinakumari K; Nair M
Oncol Rep; 1994 Jan; 1(1):245-8. PubMed ID: 21607347
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
18. Soluble immune complexes and immunoglobulin (IgG, IgA and IgM) levels in Nigerians with primary liver cell carcinoma.
Olubuyide IO; Salimonu LS; Adeniran SO
Afr J Med Med Sci; 1993 Dec; 22(4):57-62. PubMed ID: 7839931
[TBL] [Abstract][Full Text] [Related]
19. Serum immunoglobulins in squamous cell carcinoma of the oral cavity.
Khanna NN; Das SN; Khanna S
J Surg Oncol; 1982 May; 20(1):46-8. PubMed ID: 7078184
[TBL] [Abstract][Full Text] [Related]
20. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
